Recharging women’s sexual health: Taking back female sexual functionMay 6th 2022
At the American College of Obstetricians & Gynecologists’ 2022 Annual Scientific and Clinical Meeting, Lyndsey Harper, MD, FACOG, IF, and Laurie Mintz, PhD, explained how ob-gyns can help women take charge of their sexual function and how to address internalized shame, medical contributors to sexual dysfunction, and suggestions when considering a treatment plan for your patients.
Data still hazy for immediate postpartum hormonal contraception and postpartum depressionMay 6th 2022
A recent study presented at the 2022 American College of Obstetricians & Gynecologists' Annual Clinical & Scientific Meeting found that there was neither a decreased nor increased risk for postpartum depression in patients who received hormonal contraception due to insufficient evidence.
ACOG 2022 has officially begun: What to expect from the Annual Clinical & Scientific MeetingMay 6th 2022
The American College of Obstetricians & Gynecologists begins their Annual Clinical & Scientific Meeting (ACSM) today, which will continue until Sunday, May 8, 2022 in San Diego, California. Follow along for coverage.
Michal Elovitz, MD, discusses new preterm birth data at SMFMFebruary 4th 2022
In this exclusive video interview, Michal Elovitz, MD, chief medical advisor at Mirvie, discusses the latest data from the RNA testing platform in predicting preterm birth at the SMFM 42nd Annual Pregnancy Meeting.
Early gestational diabetes screening in women at risk for gestational diabetes: a randomized controlled trialFebruary 4th 2022
Researchers presented a study at the SMFM 42nd Annual Pregnancy Meeting to assess if early gestational diabetes (GDM) screening is associated with improved perinatal outcomes.
Supporting transgender and gender-expansive individuals in reproductive health careFebruary 4th 2022
At the Society for Maternal-Fetal Medicine’s 42nd Annual Meeting, a roundtable discussion explored ways to promote inclusivity and support transgender and gender-expansive individuals in the women’s health space.
Immunotherapy approvals shine light on need for molecular testing in endometrial cancerFebruary 1st 2022
Sarah Lee, MD, MBA, discusses the use of checkpoint inhibitors in endometrial cancer, research regarding the association between MSI-H, dMMR, and TMB-H disease, and the importance of broad molecular testing to ensure all eligible patients are appropriately matched to immunotherapeutic options.
Secondary cytoreductive surgery in recurrent ovarian cancer
Amer Karam, MD, discusses the role of secondary cytoreductive surgery in ovarian cancer and the need for careful patient selection, plus the results from 3 clinical trials and the key differences between these efforts.
S3E20: Brooke Faught, NP on sexual health, trauma-informed care, and the perks of meeting in-personDecember 3rd 2021
In this episode of Pap Talk, we took you with us to the North American Menopause Society's recent Annual Meeting. Sexual health specialist Michael Krychman, MD, sat down with Brooke Faught, NP, to learn more about her work at the Women's Institute for Sexual Health, her role on the NAMS Planning Committee, and her tips for talking trauma with patients.
The superior method for pelvic organ prolapse repair: Mesh or native tissue repair?November 17th 2021
At AAGL’s 50th Global Congress on MIGS, Peter L. Rosenblatt, MD, and Cheryl B. Iglesia, MD, FACOG, debated the use of native tissue repair and transvaginal mesh in pelvic reconstructive surgery.
Radiofrequency ablation for uterine fibroidsNovember 16th 2021
In a panel discussion at AAGL’s 50th Global Congress on MIGS, in Austin, Texas, Kimberly Kho, MD, MPH, along with Jessica Shepherd, MD, MBA, FACOG, and Craig Sobolewski, MD, discussed utilizing radiofrequency ablation for treatment of uterine fibroids.